INTS
Income statement / Annual
Last year (2023), Intensity Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Intensity Therapeutics, Inc.'s net income was -$10.54 M.
See Intensity Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$147,000.00 |
$179,037.00 |
$0.00 |
$0.00 |
$0.00 |
Gross Profit |
-$147,000.00 |
-$179,037.00 |
$0.00 |
$0.00 |
$0.00 |
Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
Research and Development
Expenses |
$4.79 M
|
$5.13 M
|
$5.86 M
|
$5.05 M
|
$4.44 M
|
General & Administrative
Expenses |
$3.53 M
|
$2.42 M
|
$2.16 M
|
$1.17 M
|
$1.24 M
|
Selling & Marketing
Expenses |
-$147,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$3.39 M
|
$2.42 M
|
$2.16 M
|
$1.17 M
|
$1.24 M
|
Other Expenses |
$0.00 |
$47,646.00 |
$115,513.00 |
$118,757.00 |
$144,989.00 |
Operating Expenses |
$8.17 M |
$7.55 M |
$8.01 M |
$6.22 M |
$5.68 M |
Cost And Expenses |
$8.32 M |
$7.55 M |
$8.01 M |
$6.22 M |
$5.68 M |
Interest Income |
$324,000.00 |
$2,481.00 |
$2,609.00 |
$74,009.00 |
$150,707.00 |
Interest Expense |
$305,000.00 |
$81,781.00 |
$16,767.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$147,000.00
|
$179,037.00
|
$236,558.00
|
$206,297.00
|
$171,860.00
|
EBITDA |
-$8.17 M
|
-$7.50 M
|
-$8.01 M
|
-$6.22 M
|
-$5.68 M
|
EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
-$2.22 M
|
$49,058.00
|
$118,122.00
|
$192,766.00
|
$295,696.00
|
Income Before Tax |
-$10.54 M |
-$7.58 M |
-$7.90 M |
-$6.03 M |
-$5.38 M |
Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$1.00 |
-$131,908.00 |
-$2,609.00 |
-$74,009.00 |
-$150,707.00 |
Net Income |
-$10.54 M |
-$7.45 M |
-$7.89 M |
-$5.96 M |
-$5.23 M |
Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
EPS |
-1.22 |
-0.57 |
-0.6 |
-0.45 |
-0.4 |
EPS Diluted |
-1.22 |
-0.57 |
-0.6 |
-0.45 |
-0.4 |
Weighted Average Shares
Out |
$8.62 M
|
$13.10 M
|
$13.10 M
|
$13.10 M
|
$13.10 M
|
Weighted Average Shares
Out Diluted |
$8.62 M
|
$13.10 M
|
$13.10 M
|
$13.10 M
|
$13.10 M
|
Link |
|
|
|
|
|